Answers are grounded in this paper and cite their sources.
In this living systematic review and network meta-analysis, lebrikizumab was similarly effective to dupilumab for the short-term treatment of atopic dermatitis in adults. Clinicians and patients can use these comparative data to inform treatment decisions.
No takes yet. Share an insight, caveat, or question.
Drucker et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: